Home  |  Contact

UniProtKB/Swiss-Prot P52701: Variant p.Gly566Arg

DNA mismatch repair protein Msh6
Gene: MSH6
Variant information

Variant position:  566
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LP/P [Disclaimer]
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Glycine (G) to Arginine (R) at position 566 (G566R, p.Gly566Arg).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from glycine (G) to large size and basic (R)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -2
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In CRC and HNPCC5; decreased mismatch repair activity; loss of protein expression.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  566
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  1360
The length of the canonical sequence.

Location on the sequence:   EEDSSGHTRAYGVCFVDTSL  G KFFIGQFSDDRHCSRFRTLV
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         EEDSSGH-------------TRAYGVCFVDTSLGKFFIGQFSDDRHCSRFRTLV

Mouse                         EEETSGH-------------TRVYGVCFVDTSLGKFFIGQF

Chicken                       -EDSSGQ--------------RVYGVCFVDTSVGKFYVGQF

Drosophila                    DEGTCSR----------------YGVCFIDTSIGDFHLGEF

Slime mold                    EYD------------------KQYGVCFVDVSIGEFYLCTI

Baker's yeast                 PGNFYNETQLDSSTIVQKLNTKIFGAAFIDTATGELQMLEF

Fission yeast                 LQSDNEE--------------PSFGICFIDTSTGGFHMCEF

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 1360 DNA mismatch repair protein Msh6


Literature citations

Verification of the three-step model in assessing the pathogenicity of mismatch repair gene variants.
Kansikas M.; Kariola R.; Nystroem M.;
Hum. Mutat. 32:107-115(2011)
Cited for: CHARACTERIZATION OF VARIANTS HNPCC5 LEU-128; ILE-144; ARG-566; LEU-623; THR-728; GLY-881 DELINS LYS-SER; THR-1087; HIS-1095; LYS-1193 AND GLN-1354; CHARACTERIZATION OF VARIANT ARG-1087; FUNCTION;

Germ-line msh6 mutations in colorectal cancer families.
Kolodner R.D.; Tytell J.D.; Schmeits J.L.; Kane M.F.; Das Gupta R.; Weger J.; Wahlberg S.; Fox E.A.; Peel D.; Ziogas A.; Garber J.E.; Syngal S.; Anton-Culver H.; Li F.P.;
Cancer Res. 59:5068-5074(1999)
Cited for: VARIANTS CRC ILE-285; ARG-566; GLY-803 AND THR-1087; VARIANTS GLU-39; ASP-220; VAL-396 AND LEU-800;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.